Journal of cutaneous medicine and surgery · 2019
Treatment of Mycoplasma pneumoniae-Induced Rash and Mucositis With Cyclosporine.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Heidi Oi-Yee, Colantonio Sophia, Ramien Michele L
Аннотация
BACKGROUND: Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a relatively newly recognized clinical entity that typically presents with predominant mucositis accompanied by variable cutaneous involvement 7-9 days after the onset of prodromal symptoms. There are no evidence-based guidelines for treatment, and current standards of care may include supportive therapy, antibiotics, corticosteroids, and intravenous immunoglobulin .
OBJECTIVE: This case series aims to describe the potential efficacy of cyclosporine A (CsA) in the treatment of MIRM.
METHODS: The present case series details our use of CsA early in the course of MIRM in 3 pediatric patients.
RESULTS: Rapid clinical resolution was observed following CsA therapy.
CONCLUSIONS: We suggest that early initiation of CsA may be an effective therapeutic option for MIRM.
OBJECTIVE: This case series aims to describe the potential efficacy of cyclosporine A (CsA) in the treatment of MIRM.
METHODS: The present case series details our use of CsA early in the course of MIRM in 3 pediatric patients.
RESULTS: Rapid clinical resolution was observed following CsA therapy.
CONCLUSIONS: We suggest that early initiation of CsA may be an effective therapeutic option for MIRM.